The week kicks off with semiconductors dominating sentiment. SMCI surged Monday on short covering. Short interest sits at 13.4% of free float — down from a June peak near 15.9%. Options traders are betting on more upside. Short-dated calls stack up through June 26. NVDA shows different dynamics: short interest is just 1.25% of free float. Yet NVDA carries the densest options chain in the sector, with zero-day contracts active today. MU reports earnings this Wednesday after the close. Memory chip demand for AI servers is the key focus. Options activity around the June 24–26 dates is heavy.
ACN is under broad Wall Street pressure. TD Cowen cut to Hold with a $150 target, down from $258. Truist also maintained Hold, trimming to $150. RBC and Susquehanna made sharp cuts as well. The concern is consistent: AI disruption is hurting consulting demand. ACN's market cap stands at $78.3 billion.
The biggest insider move this week came from WMT. The Walton Family Holdings Trust sold $535 million in shares on June 16. That's 4.4 million shares at roughly $121 each. AMAT executives also unloaded heavily. CEO Gary Dickerson sold $49.2 million. CTO and board members added another $31 million. Total AMAT insider sales topped $80 million in two days.
HTZ is flashing squeeze signals. Utilization hit 95.3%. Availability collapsed to just 5.7% of short interest. With 44% of free float shorted, any positive catalyst could force rapid covering. Separately, Tradeweb Markets saw cost to borrow surge 131% in one week to 0.44%. Short supply is tightening fast.
Arrowhead Pharmaceuticals received European Commission marketing authorisation today for REDEMPLO. The drug treats familial chylomicronemia syndrome. It's a clean regulatory win and a rare piece of positive drug news to close the week.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
